Blog
RSS FeedPosted by Michael Wonder on 21 Jun 2017
Takeda and TiGenix announce that Swissmedic has accepted for review the file on Cx601 for the treatment of complex perianal fistulas in Crohn’s disease patients
19 June 2017 - Takeda and TiGenix today announced that the Swiss Agency for Therapeutic Products (Swissmedic) has accepted for ...